Literature DB >> 11510889

Influence of 72% injury in one kidney on several organs involved in guanidino compound metabolism: a time course study.

O Levillain1, B Marescau, I Possemiers, M Al Banchaabouchi, P P De Deyn.   

Abstract

Arginine (Arg) produced from citrulline originates mostly from kidneys. Arg is involved in guanidino compound biosynthesis, which requires interorgan co-operation. In renal insufficiency, citrulline accumulates in the plasma in proportion to renal damage. Thus, disturbances in Arg and guanidino compound metabolism are expected in several tissues. An original use of the model of nephrectomy based on ligating branches of the renal artery allowed us to investigate Arg and guanidino compound metabolism simultaneously in injured (left) and healthy (right) kidneys. The left kidney of adult rats was subjected to 72% nephrectomy. Non-operated, sham-operated and nephrectomized rats were studied for a period of 21 days. Constant renal growth was observed only in the healthy kidneys. Guanidino compound levels were modified transiently during the first 48 h. The metabolism and/or tissue content of several guanidino compounds were disturbed throughout the experimental period. Arg synthesis was greatly reduced in the injured kidney, while it increased in the healthy kidney. The renal production of guanidinoacetic acid decreased in the injured kidney and its urinary excretion was reduced. The experimentally proven toxins alpha-keto-delta-guanidinovaleric acid and guanidinosuccinic acid (GSA) accumulated only in the injured kidney. The urinary excretion of GSA and methylguanidine increased in nephrectomized rats. When the injured kidney grew again, the level of some guanidino compounds tended to normalize. Nephrectomy affected the guanidino compound levels and metabolism in muscles and liver. In conclusion, the specific accumulation of toxic guanidino compounds in the injured kidney reflects disturbances in renal metabolism and function. The healthy kidney compensates for the injured kidney's loss of metabolic functions (e.g. Arg: production). This model is excellent for investigating renal metabolism when a disease destroys a limited area in one kidney, as is observed in patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11510889     DOI: 10.1007/s004240100581

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  3 in total

1.  SLCO4C1 transporter eliminates uremic toxins and attenuates hypertension and renal inflammation.

Authors:  Takafumi Toyohara; Takehiro Suzuki; Ryo Morimoto; Yasutoshi Akiyama; Tomokazu Souma; Hiromi O Shiwaku; Yoichi Takeuchi; Eikan Mishima; Michiaki Abe; Masayuki Tanemoto; Satohiro Masuda; Hiroaki Kawano; Koji Maemura; Masaaki Nakayama; Hiroshi Sato; Tsuyoshi Mikkaichi; Hiroaki Yamaguchi; Shigefumi Fukui; Yoshihiro Fukumoto; Hiroaki Shimokawa; Ken-ichi Inui; Tetsuya Terasaki; Junichi Goto; Sadayoshi Ito; Takanori Hishinuma; Isabelle Rubera; Michel Tauc; Yoshiaki Fujii-Kuriyama; Hikaru Yabuuchi; Yoshinori Moriyama; Tomoyoshi Soga; Takaaki Abe
Journal:  J Am Soc Nephrol       Date:  2009-10-29       Impact factor: 10.121

2.  Spaceflight Activates Autophagy Programs and the Proteasome in Mouse Liver.

Authors:  Elizabeth A Blaber; Michael J Pecaut; Karen R Jonscher
Journal:  Int J Mol Sci       Date:  2017-09-27       Impact factor: 5.923

Review 3.  Acute Kidney Injury and Organ Dysfunction: What Is the Role of Uremic Toxins?

Authors:  Jesús Iván Lara-Prado; Fabiola Pazos-Pérez; Carlos Enrique Méndez-Landa; Dulce Paola Grajales-García; José Alfredo Feria-Ramírez; Juan José Salazar-González; Mario Cruz-Romero; Alejandro Treviño-Becerra
Journal:  Toxins (Basel)       Date:  2021-08-09       Impact factor: 4.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.